Procter & Gamble Company (PG) Stock Forecast, Price Target & Predictions
PG Stock Forecast
Procter & Gamble Company stock forecast is as follows: an average price target of $156.05 (represents a -10.36% downside from PG’s last price of $174.08) and a rating consensus of 'Buy', based on 19 wall street analysts offering a 1-year stock forecast.
PG Price Target
PG Analyst Ratings
Procter & Gamble Company Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jul 24, 2024 | Kaumil Gajrawala | Jefferies | $175.00 | $165.93 | 5.47% | 0.53% |
Jul 22, 2024 | Mark Astrachan | Stifel Nicolaus | $161.00 | $167.96 | -4.14% | -7.51% |
Jul 18, 2024 | Robert Ottenstein | Evercore ISI | $183.00 | $169.44 | 8.00% | 5.12% |
Jul 17, 2024 | Steve Powers | Deutsche Bank | $176.00 | $168.53 | 4.43% | 1.10% |
Jun 24, 2024 | Kevin Grundy | BNP Paribas | $187.00 | $168.26 | 11.14% | 7.42% |
Apr 25, 2024 | Chris Graja | Argus Research | $185.00 | $162.88 | 13.58% | 6.27% |
Apr 23, 2024 | Lauren Lieberman | Barclays | $170.00 | $160.54 | 5.89% | -2.34% |
Nov 24, 2023 | Alexia Howard | Bernstein | $40.00 | $151.38 | -73.58% | -77.02% |
Oct 18, 2023 | Dara Mohsenian | Morgan Stanley | $174.00 | $146.26 | 18.97% | -0.05% |
Jan 13, 2023 | Olivia Tong | Raymond James | $170.00 | $150.25 | 13.14% | -2.34% |
Procter & Gamble Company Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 5 | 9 |
Avg Price Target | - | $176.40 | $161.22 |
Last Closing Price | $174.08 | $174.08 | $174.08 |
Upside/Downside | -100.00% | 1.33% | -7.39% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jul 31, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
Jul 24, 2024 | Jefferies | - | Hold | Downgrade |
Jul 22, 2024 | Cowen & Co. | - | Buy | Initialise |
Jul 19, 2024 | Barclays | Overweight | Overweight | Hold |
Jul 18, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Jul 17, 2024 | Deutsche Bank | Buy | Buy | Hold |
Jul 10, 2024 | Citigroup | Buy | Buy | Hold |
Jun 24, 2024 | Exane BNP Paribas | - | Outperform | Initialise |
Apr 12, 2024 | Barclays | Overweight | Overweight | Hold |
Apr 03, 2024 | Deutsche Bank | Buy | Buy | Hold |
Procter & Gamble Company Financial Forecast
Procter & Gamble Company Revenue Forecast
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $21.44B | $21.87B | $20.55B | $20.07B | $20.77B | $20.61B | - | $19.38B | $20.95B | $20.34B | $18.95B | $18.11B | $19.75B | $19.32B | $17.70B | $17.21B |
Avg Forecast | $22.98B | $22.48B | $23.65B | $23.86B | $22.13B | $21.60B | $22.76B | $22.94B | $21.41B | $20.86B | $21.94B | $22.08B | $20.72B | $20.43B | $21.48B | $21.58B | $20.01B | $19.28B | $20.75B | $20.37B | $19.40B | $18.71B | $20.33B | $19.83B | $18.37B | $17.96B | $19.27B | $18.38B | $16.95B | $17.31B |
High Forecast | $23.44B | $22.93B | $24.12B | $24.34B | $22.57B | $22.03B | $23.21B | $23.40B | $21.83B | $21.27B | $22.38B | $22.17B | $21.14B | $20.84B | $21.74B | $22.01B | $20.41B | $19.66B | $21.16B | $20.77B | $19.40B | $18.99B | $20.64B | $20.12B | $18.65B | $18.23B | $19.56B | $18.65B | $17.20B | $17.57B |
Low Forecast | $22.80B | $22.30B | $23.47B | $23.67B | $21.96B | $21.43B | $22.58B | $22.76B | $21.24B | $20.69B | $21.77B | $21.96B | $20.56B | $20.28B | $21.09B | $21.41B | $19.85B | $19.13B | $20.58B | $20.21B | $19.40B | $18.50B | $20.11B | $19.61B | $18.17B | $17.76B | $19.06B | $18.17B | $16.76B | $17.12B |
# Analysts | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 8 | 6 | 5 | 14 | 9 | 10 | 16 | 9 | 10 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.01% | 1.03% | 1.04% | 1.00% | 1.01% | - | 1.04% | 1.03% | 1.03% | 1.03% | 1.01% | 1.02% | 1.05% | 1.04% | 0.99% |
Procter & Gamble Company EBITDA Forecast
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 8 | 6 | 5 | 14 | 9 | 10 | 16 | 9 | 10 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.43B | $5.77B | $5.18B | $5.20B | $5.01B | $5.78B | - | $4.18B | $6.01B | $5.84B | $4.39B | $4.69B | $5.66B | $6.07B | $4.45B | $4.36B |
Avg Forecast | $6.21B | $6.08B | $6.39B | $6.45B | $5.98B | $5.84B | $6.15B | $6.20B | $5.79B | $5.64B | $5.93B | $5.97B | $5.60B | $5.70B | $5.81B | $5.84B | $5.41B | $5.18B | $5.61B | $6.34B | $5.20B | $4.71B | $5.97B | $5.77B | $4.19B | $4.41B | $5.17B | $5.17B | $3.79B | $4.20B |
High Forecast | $6.34B | $6.20B | $6.52B | $6.58B | $6.10B | $5.96B | $6.28B | $6.33B | $5.90B | $5.75B | $6.05B | $5.99B | $5.72B | $6.84B | $5.88B | $5.95B | $5.52B | $6.21B | $5.72B | $7.61B | $5.20B | $5.65B | $7.17B | $6.92B | $5.02B | $5.29B | $6.21B | $6.21B | $4.54B | $5.04B |
Low Forecast | $6.17B | $6.03B | $6.35B | $6.40B | $5.94B | $5.79B | $6.11B | $6.16B | $5.74B | $5.60B | $5.89B | $5.94B | $5.56B | $4.56B | $5.70B | $5.79B | $5.37B | $4.14B | $5.57B | $5.08B | $5.20B | $3.77B | $4.78B | $4.61B | $3.35B | $3.53B | $4.14B | $4.14B | $3.03B | $3.36B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.76% | 0.99% | 0.96% | 1.00% | 0.89% | 0.91% | - | 0.89% | 1.01% | 1.01% | 1.05% | 1.06% | 1.09% | 1.17% | 1.17% | 1.04% |
Procter & Gamble Company Net Income Forecast
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 8 | 6 | 5 | 14 | 9 | 10 | 16 | 9 | 10 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $16.20M | $4.52B | $3.38B | $3.40B | $3.93B | $3.94B | - | $3.35B | $4.24B | $4.11B | $2.91B | $3.27B | $3.85B | $4.28B | $2.80B | $2.92B |
Avg Forecast | $4.36B | $4.60B | $5.54B | $5.37B | $3.97B | $4.29B | $5.13B | $4.98B | $3.72B | $3.99B | $4.83B | $4.71B | $3.40B | $3.93B | $4.20B | $4.25B | $3.27B | $3.58B | $3.92B | $4.47B | $3.02B | $3.25B | $4.20B | $4.06B | $2.77B | $3.08B | $3.52B | $3.64B | $2.38B | $2.81B |
High Forecast | $4.47B | $4.72B | $5.69B | $5.51B | $4.07B | $4.40B | $5.26B | $5.11B | $3.82B | $4.09B | $4.96B | $4.81B | $3.48B | $4.72B | $4.25B | $4.36B | $3.36B | $4.29B | $4.02B | $5.36B | $3.02B | $3.90B | $5.04B | $4.87B | $3.33B | $3.69B | $4.23B | $4.37B | $2.86B | $3.38B |
Low Forecast | $4.32B | $4.56B | $5.49B | $5.31B | $3.93B | $4.25B | $5.08B | $4.93B | $3.68B | $3.95B | $4.78B | $4.59B | $3.36B | $3.15B | $4.10B | $4.21B | $3.24B | $2.86B | $3.88B | $3.57B | $3.02B | $2.60B | $3.36B | $3.25B | $2.22B | $2.46B | $2.82B | $2.92B | $1.91B | $2.25B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 1.06% | 1.03% | 0.95% | 1.00% | 0.88% | - | 1.03% | 1.01% | 1.01% | 1.05% | 1.06% | 1.09% | 1.17% | 1.17% | 1.04% |
Procter & Gamble Company SG&A Forecast
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 8 | 6 | 5 | 14 | 9 | 10 | 16 | 9 | 10 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $5.52B | $5.60B | $5.78B | $5.42B | $5.09B | $4.83B | - | $5.03B | $5.12B | $4.95B | $5.62B | $5.40B | $5.11B | $4.89B | $5.28B | $5.04B |
Avg Forecast | $6.07B | $5.94B | $6.25B | $6.30B | $5.84B | $5.70B | $6.01B | $6.06B | $5.65B | $5.51B | $5.79B | $5.83B | $5.47B | $5.90B | $5.67B | $5.70B | $5.28B | $5.36B | $5.48B | $5.38B | $5.24B | $4.88B | $5.09B | $4.89B | $5.36B | $5.08B | $4.67B | $4.17B | $4.49B | $4.87B |
High Forecast | $6.19B | $6.05B | $6.37B | $6.43B | $5.96B | $5.82B | $6.13B | $6.18B | $5.77B | $5.62B | $5.91B | $5.85B | $5.58B | $7.08B | $5.74B | $5.81B | $5.39B | $6.43B | $5.59B | $6.45B | $5.24B | $5.85B | $6.11B | $5.87B | $6.43B | $6.10B | $5.61B | $5.01B | $5.39B | $5.84B |
Low Forecast | $6.02B | $5.89B | $6.20B | $6.25B | $5.80B | $5.66B | $5.96B | $6.01B | $5.61B | $5.46B | $5.75B | $5.80B | $5.43B | $4.72B | $5.57B | $5.65B | $5.24B | $4.29B | $5.44B | $4.30B | $5.24B | $3.90B | $4.07B | $3.91B | $4.28B | $4.07B | $3.74B | $3.34B | $3.59B | $3.89B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.97% | 0.98% | 1.09% | 1.01% | 0.93% | 0.90% | - | 1.03% | 1.01% | 1.01% | 1.05% | 1.06% | 1.09% | 1.17% | 1.17% | 1.04% |
Procter & Gamble Company EPS Forecast
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 8 | 6 | 5 | 14 | 9 | 10 | 16 | 9 | 10 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.01 | $1.89 | $1.40 | $1.41 | $1.63 | $1.62 | - | $1.37 | $1.76 | $1.66 | $1.16 | $1.30 | $1.53 | $1.69 | $1.10 | $1.15 |
Avg Forecast | $1.76 | $1.86 | $2.24 | $2.17 | $1.61 | $1.73 | $2.07 | $2.01 | $1.51 | $1.61 | $1.95 | $1.91 | $1.37 | $1.42 | $1.70 | $1.72 | $1.32 | $1.32 | $1.59 | $1.55 | $1.22 | $1.29 | $1.65 | $1.59 | $1.08 | $1.19 | $1.51 | $1.42 | $1.01 | $1.13 |
High Forecast | $1.81 | $1.91 | $2.30 | $2.23 | $1.65 | $1.78 | $2.13 | $2.07 | $1.54 | $1.65 | $2.00 | $1.95 | $1.41 | $1.45 | $1.72 | $1.76 | $1.36 | $1.36 | $1.63 | $1.59 | $1.22 | $1.32 | $1.68 | $1.62 | $1.11 | $1.21 | $1.54 | $1.45 | $1.03 | $1.15 |
Low Forecast | $1.75 | $1.84 | $2.22 | $2.15 | $1.59 | $1.72 | $2.05 | $1.99 | $1.49 | $1.60 | $1.93 | $1.86 | $1.36 | $1.40 | $1.66 | $1.70 | $1.31 | $1.31 | $1.57 | $1.54 | $1.22 | $1.27 | $1.63 | $1.57 | $1.07 | $1.17 | $1.49 | $1.40 | $1.00 | $1.12 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 1.10% | 1.06% | 1.07% | 1.03% | 1.04% | - | 1.06% | 1.07% | 1.04% | 1.07% | 1.09% | 1.01% | 1.19% | 1.09% | 1.02% |
Procter & Gamble Company Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
EL | Estée Lauder Companies | $84.56 | $176.72 | 108.99% | Hold |
ELF | e.l.f. Beauty | $116.63 | $172.55 | 47.95% | Buy |
COTY | Coty | $9.11 | $12.61 | 38.42% | Buy |
CHD | Church & Dwight | $104.04 | $111.00 | 6.69% | Buy |
KMB | Kimberly-Clark | $143.52 | $144.15 | 0.44% | Hold |
KVUE | Kenvue | $23.39 | $22.00 | -5.94% | Buy |
UL | Unilever | $65.06 | $59.00 | -9.31% | Buy |
PG | Procter & Gamble Company | $174.08 | $156.05 | -10.36% | Buy |
CLX | Clorox Company | $166.27 | $146.67 | -11.79% | Hold |
CL | Colgate-Palmolive Company | $105.73 | $90.75 | -14.17% | Buy |
PG Forecast FAQ
Is Procter & Gamble Company a good buy?
Yes, according to 19 Wall Street analysts, Procter & Gamble Company (PG) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 13 'Buy' recommendations, accounting for 68.42% of PG's total ratings.
What is PG's price target?
Procter & Gamble Company (PG) average price target is $156.05 with a range of $40 to $187, implying a -10.36% from its last price of $174.08. The data is based on 19 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Procter & Gamble Company stock go up soon?
According to Wall Street analysts' prediction for PG stock, the company can go down by -10.36% (from the last price of $174.08 to the average price target of $156.05), up by 7.42% based on the highest stock price target, and down by -77.02% based on the lowest stock price target.
Can Procter & Gamble Company stock reach $300?
PG's average twelve months analyst stock price target of $156.05 does not support the claim that Procter & Gamble Company can reach $300 in the near future.
What are Procter & Gamble Company's analysts' financial forecasts?
Procter & Gamble Company's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $89.43B (high $91.21B, low $88.73B), average EBITDA is $24.18B (high $24.66B, low $23.99B), average net income is $18.37B (high $18.84B, low $18.18B), average SG&A $23.61B (high $24.09B, low $23.43B), and average EPS is $7.43 (high $7.62, low $7.35). PG's analysts financial forecasts for the fiscal year (Jun 2027) are as follows: average revenue is $92.97B (high $94.82B, low $92.25B), average EBITDA is $25.14B (high $25.64B, low $24.94B), average net income is $19.87B (high $20.39B, low $19.67B), average SG&A $24.55B (high $25.04B, low $24.36B), and average EPS is $8.04 (high $8.25, low $7.96).
Did the PG's actual financial results beat the analysts' financial forecasts?
Based on Procter & Gamble Company's last annual report (Jun 2023), the company's revenue was $82.01B, which missed the average analysts forecast of $99.81B by -17.84%. Apple's EBITDA was $21.82B, missing the average prediction of $27.74B by -21.33%. The company's net income was $14.65B, missing the average estimation of $18.26B by -19.76%. Apple's SG&A was $21.11B, missing the average forecast of $26.74B by -21.04%. Lastly, the company's EPS was $6.07, missing the average prediction of $7.01 by -13.39%. In terms of the last quarterly report (Dec 2023), Procter & Gamble Company's revenue was $21.44B, missing the average analysts' forecast of $21.48B by -0.16%. The company's EBITDA was $4.43B, missing the average prediction of $5.81B by -23.66%. Procter & Gamble Company's net income was $16.2M, missing the average estimation of $4.2B by -99.61%. The company's SG&A was $5.52B, missing the average forecast of $5.67B by -2.63%. Lastly, the company's EPS was $0.0066, missing the average prediction of $1.7 by -99.61%